Marshall Wace, LLP Evolus, Inc. Transaction History

Marshall Wace, LLP

  • $72.2 Billion
  • Q2 2024

A detailed history of Marshall Wace, LLP transactions in Evolus, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 201,849 shares of EOLS stock, worth $3.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
201,849
Previous 218,300 7.54%
Holding current value
$3.27 Million
Previous $3.06 Million 28.34%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$10.45 - $13.76 $171,912 - $226,365
-16,451 Reduced 7.54%
201,849 $2.19 Million
Q1 2024

May 15, 2024
SELL
$9.99 - $14.91 $3.35 Million - $5 Million
-335,226 Reduced 60.56%
218,300 $3.06 Million
Q4 2023

Feb 14, 2024
SELL
$7.6 - $10.53 $925,908 - $1.28 Million
-121,830 Reduced 18.04%
553,526 $5.83 Million
Q3 2023

Nov 14, 2023
SELL
$7.15 - $10.2 $2.58 Million - $3.69 Million
-361,518 Reduced 34.87%
675,356 $6.17 Million
Q2 2023

Aug 14, 2023
BUY
$7.23 - $10.52 $6.69 Million - $9.74 Million
925,963 Added 834.87%
1,036,874 $7.54 Million
Q1 2023

May 15, 2023
BUY
$7.81 - $11.05 $866,214 - $1.23 Million
110,911 New
110,911 $938,000
Q3 2022

Nov 14, 2022
BUY
$7.76 - $13.72 $1.45 Million - $2.56 Million
186,874 New
186,874 $1.51 Million
Q2 2022

Aug 15, 2022
SELL
$10.22 - $13.94 $172,748 - $235,627
-16,903 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$5.22 - $11.78 $88,233 - $199,117
16,903 New
16,903 $190,000
Q4 2021

Feb 14, 2022
SELL
$5.37 - $8.38 $1.37 Million - $2.14 Million
-255,537 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$7.36 - $13.67 $1.71 Million - $3.18 Million
-232,882 Reduced 47.68%
255,537 $1.95 Million
Q2 2021

Aug 13, 2021
BUY
$8.42 - $13.96 $1.85 Million - $3.08 Million
220,296 Added 82.16%
488,419 $6.18 Million
Q1 2021

May 17, 2021
BUY
$3.2 - $16.51 $857,993 - $4.43 Million
268,123 New
268,123 $3.48 Million

Others Institutions Holding EOLS

# of Institutions
163
Shares Held
49.1M
Call Options Held
453K
Put Options Held
14K
View Full List

About Evolus, Inc.

EOLS Quotes by TradingView
  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $909M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email